Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,873 | 254 | 99.0% |
| Education | $40.90 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $645.71 | 50 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $593.52 | 30 | $0 (2020) |
| GlaxoSmithKline, LLC. | $432.53 | 31 | $0 (2022) |
| Radius Health, Inc. | $304.07 | 16 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $283.55 | 21 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $253.20 | 17 | $0 (2020) |
| Allergan, Inc. | $188.36 | 14 | $0 (2020) |
| Amgen Inc. | $180.42 | 13 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $168.41 | 14 | $0 (2018) |
| Abbott Laboratories | $144.33 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $131.81 | 2 | Abbott Laboratories ($116.71) |
| 2022 | $83.67 | 6 | GlaxoSmithKline, LLC. ($45.54) |
| 2021 | $317.85 | 20 | Mylan Specialty L.P. ($76.81) |
| 2020 | $775.55 | 51 | AstraZeneca Pharmaceuticals LP ($150.93) |
| 2019 | $905.49 | 52 | AstraZeneca Pharmaceuticals LP ($281.69) |
| 2018 | $836.06 | 60 | Novo Nordisk Inc ($190.85) |
| 2017 | $863.89 | 67 | Novo Nordisk Inc ($161.06) |
All Payment Transactions
258 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/18/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $116.71 | General |
| Category: Neuromodulation | ||||||
| 02/14/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Endocrinology | ||||||
| 11/02/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Bone Health | ||||||
| 06/14/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: RESPIRATORY | ||||||
| 05/05/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: VACCINES | ||||||
| 04/19/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: VACCINES | ||||||
| 01/11/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 01/11/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Diabetes Care | ||||||
| 09/15/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: UROLOGY | ||||||
| 07/30/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Diabetes Care | ||||||
| 06/09/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Bone Health | ||||||
| 05/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Diabetes | ||||||
| 05/12/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: DIABETES | ||||||
| 04/26/2021 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/19/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/15/2021 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/12/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: RESPIRATORY | ||||||
| 03/29/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Diabetes | ||||||
| 03/24/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: UROLOGY | ||||||
| 03/22/2021 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/10/2021 | Amgen Inc. | — | Education | In-kind items and services | $13.89 | General |
| 03/10/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Bone Health | ||||||
| 03/08/2021 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/04/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 17 | 24 | $4,920 | $2,170 |
| 2022 | 3 | 118 | 130 | $13,050 | $6,302 |
| 2021 | 16 | 2,541 | 2,600 | $169,076 | $107,360 |
| 2020 | 22 | 1,119 | 1,853 | $244,086 | $96,191 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 24 | $4,920 | $2,170 | 44.1% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 73 | 74 | $4,070 | $2,820 | 69.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 31 | $6,355 | $2,359 | 37.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 25 | $2,625 | $1,123 | 42.8% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 1,230 | 1,236 | $67,980 | $47,821 | 70.3% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 345 | 345 | $18,975 | $13,348 | 70.3% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 310 | 310 | $17,050 | $11,994 | 70.3% |
| 0064A | Fee covid-19 vac 7 res | Office | 2021 | 273 | 273 | $15,015 | $10,562 | 70.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 104 | $21,320 | $7,939 | 37.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 71 | $7,455 | $4,312 | 57.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 35 | 36 | $7,488 | $3,747 | 50.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 22 | 22 | $3,960 | $2,837 | 71.6% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 70 | 70 | $3,850 | $2,708 | 70.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 19 | $1,178 | $785.39 | 66.7% |
| 0004A | Fee covid-19 vac 1 res | Office | 2021 | 12 | 12 | $660.00 | $464.28 | 70.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 15 | 15 | $450.00 | $272.25 | 60.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 11 | $385.00 | $181.17 | 47.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 17 | 19 | $617.31 | $172.05 | 27.9% |
| 81002 | Urinalysis, manual test | Office | 2021 | 33 | 37 | $333.00 | $128.76 | 38.7% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2021 | 20 | 20 | $2,360 | $87.60 | 3.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 207 | 456 | $93,480 | $30,134 | 32.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 148 | 206 | $42,848 | $18,722 | 43.7% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2020 | 27 | 30 | $36,000 | $14,436 | 40.1% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 78 | 400 | $20,000 | $11,052 | 55.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 59 | 59 | $10,620 | $6,661 | 62.7% |
About Dr. Desmar Walkes, M.D
Dr. Desmar Walkes, M.D is a Family Medicine healthcare provider based in Bastrop, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831138767.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Desmar Walkes, M.D has received a total of $3,914 in payments from pharmaceutical and medical device companies, with $131.81 received in 2024. These payments were reported across 258 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,873).
As a Medicare-enrolled provider, Walkes has provided services to 3,795 Medicare beneficiaries, totaling 4,607 services with total Medicare billing of $212,022. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Bastrop, TX
- Active Since 06/06/2006
- Last Updated 07/03/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831138767
Products in Payments
- FARXIGA (Drug) $305.53
- Tymlos (Biological) $304.07
- Saxenda (Drug) $274.31
- Ozempic (Drug) $234.81
- SYMBICORT (Drug) $187.90
- TRELEGY ELLIPTA (Drug) $185.26
- JARDIANCE (Drug) $181.05
- Yupelri (Drug) $137.37
- VRAYLAR (Drug) $135.96
- PROCLAIM (Device) $116.71
- BREO (Drug) $114.91
- TOUJEO (Drug) $102.15
- SOLIQUA 100/33 (Biological) $90.29
- EVENITY (Biological) $81.00
- ANORO (Drug) $75.35
- Prolia (Biological) $71.64
- Trintellix (Drug) $71.41
- TRULICITY (Drug) $68.52
- TRADJENTA (Drug) $67.55
- Utibron (Drug) $66.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bastrop
Tahir Qayyum, Md, MD
Family Medicine — Payments: $19,802
Dr. Pompeyo Chavez, Md, MD
Family Medicine — Payments: $13,487
Dr. Laurier Vocal, Md, MD
Family Medicine — Payments: $12,679
Allen Jarzombek, Md, MD
Family Medicine — Payments: $7,725
James Smith, M.d, M.D
Family Medicine — Payments: $2,562
Sammy Lerma, M.d, M.D
Family Medicine — Payments: $2,498